Medtronic plc Market Cap ($104.84 Billion)
Market Cap & Net Worth: Medtronic plc (MDTC34)
Medtronic plc market cap. Medtronic plc (SA:MDTC34) has a market capitalization of $104.84 Billion (R$534.32 Billion) as of November 1, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #241 globally and #8 in its home market, demonstrating a -6.39% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Medtronic plc's stock price R$208.39 by its total outstanding shares 2564028416 (2.56 Billion). Also see how efficiently does Medtronic plc generate cash for how efficiently the company converts equity into cash flow.
Medtronic plc Market Cap History (2016–2026)
Medtronic plc market cap history from 2016 to 2026. Data shows growth from $49.34 Billion to $33.14 Billion (6.08% CAGR). Check MDTC34 stock price for real-time trading data and today's change.
Medtronic plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Medtronic plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore how fast is Medtronic plc growing its equity to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.91x
Medtronic plc's market cap is 0.91 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.90x
Medtronic plc's market cap is 6.90 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $97.26 Billion | $30.56 Billion | $4.63 Billion | 3.18x | 21.00x |
| 2020 | $132.48 Billion | $28.91 Billion | $4.79 Billion | 4.58x | 27.66x |
| 2021 | $132.50 Billion | $30.12 Billion | $3.61 Billion | 4.40x | 36.74x |
| 2022 | $96.93 Billion | $31.69 Billion | $5.04 Billion | 3.06x | 19.24x |
| 2023 | $99.02 Billion | $31.23 Billion | $3.76 Billion | 3.17x | 26.35x |
| 2024 | $123.56 Billion | $32.36 Billion | $3.68 Billion | 3.82x | 33.61x |
| 2025 | $133.83 Billion | $33.54 Billion | $4.66 Billion | 3.99x | 28.70x |
| 2026 | $33.14 Billion | $36.36 Billion | $4.80 Billion | 0.91x | 6.90x |
Competitor Companies of MDTC34 by Market Capitalization
Companies near Medtronic plc in the global market cap rankings as of November 1, 2026. Also see MDTC34 total asset value for a full breakdown of the balance sheet.
Key companies related to Medtronic plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #114 globally with a market cap of $184.67 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #215 globally with a market cap of $111.95 Billion USD.
- Medtronic PLC (XETRA:2M6): Ranked #322 globally with a market cap of $83.04 Billion USD ( €71.03 Billion EUR).
- Boston Scientific Corp (NYSE:BSX): Ranked #443 globally with a market cap of $62.40 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #114 | Abbott Laboratories | NYSE:ABT | $184.67 Billion | $106.20 |
| #215 | Stryker Corporation | NYSE:SYK | $111.95 Billion | $291.86 |
| #322 | Medtronic PLC | XETRA:2M6 | $83.04 Billion | €69.20 |
| #443 | Boston Scientific Corp | NYSE:BSX | $62.40 Billion | $41.98 |
Market Capitalization of Medtronic plc (2016–2026)
Market capitalization of Medtronic plc from 2016 to today. Between 2016 and today, Medtronic plc's market cap moved from $49.34 Billion to $ 33.14 Billion, with a yearly change of 6.08%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$33.14 Billion | -75.24% |
| 2025 | R$133.83 Billion | +8.31% |
| 2024 | R$123.56 Billion | +24.79% |
| 2023 | R$99.02 Billion | +2.15% |
| 2022 | R$96.93 Billion | -26.84% |
| 2021 | R$132.50 Billion | +0.01% |
| 2020 | R$132.48 Billion | +36.21% |
| 2019 | R$97.26 Billion | +25.84% |
| 2018 | R$77.28 Billion | +39.67% |
| 2017 | R$55.33 Billion | +12.15% |
| 2016 | R$49.34 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of Medtronic plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $104.84 Billion USD |
| MoneyControl | $104.84 Billion USD |
| MarketWatch | $104.84 Billion USD |
| marketcap.company | $104.84 Billion USD |
| Reuters | $104.84 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Medtronic plc
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor sy… Read more